what it was like to find a treatment that worked for her, and her role as a patient advocate helping other people. SheKnows: ...

Incyte is preparing to take an oral JAK inhibitor into phase 3 trials for the skin depigmentation ... “Vitiligo often has a significant impact on patients’ lives, and there is a need for new ...

Injection of an antibody treatment durably reversed depigmentation in mice with vitiligo, as evidenced by the darkening of the tail (right), compared to control mice with vitiligo (left).

Full repigmentation is unusual and depigmentation after phototherapy ... areas of normal skin into areas of stable vitiligo. This method of treatment is still being developed and is not yet ...

If approved, Opzelura would provide an alternative to steroid drugs currently used to treat vitiligo, a chronic autoimmune disease that causes depigmentation ... the course of treatment, at ...

Narrow-band ultraviolet B phototherapy improved the efficacy of ritlecitinib for the treatment of patients with nonsegmental vitiligo, according to a study.“To achieve optimal results in vitiligo, we ...

A new study published in The Journal of Dermatological Treatment showed that for vitiligo patients, phototherapy combined with topical antioxidants, corticosteroids, or calcineurin inhibitors ...

The combination of a targeted oral medication with light therapy may enhance repigmentation for patients living with nonsegmental vitiligo, a team of ...

In a survey of pediatric patients with vitiligo, only 51.4% were offered narrowband ultraviolet B (NB-UVB) phototherapy, and 45.1% received this treatment before the age of 18 years. The main ...

Treatment: Treatment options for vitiligo aim to restore skin color ... or calcineurin inhibitors), phototherapy (using UV light), depigmentation (lightening unaffected skin to match vitiligo ...

Both drs noted that vitiligo can often be confused with other ... 30% of patients experiencing over a 75% improvement in the facial depigmentation index (F-VASI) after 24 weeks of treatment, and more ...